| Novartis Pharma Schweiz AG - Myfortic 360 mg, magensaftresistente Filmtabletten | | 56115 | | 02 | | Myfortic 360 mg | | magensaftresistente Filmtabletten | | L04AA06 | | Mycophenolic Acid | | 24.10.2002 | | |
| | Composition | | acidum mycophenolicum 360 mg ut natrii mycophenolas, lactosum 90 mg, crospovidonum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, maydis amylum, hypromellosi phthalas, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | magensaftresistente Filmtabletten | | | | | Active Agent | Dose |
|---|
| Mycophenolic Acid | 360 mg |
| | BAG: Active Agent | Dose |
|---|
| Mycophenolic Acid | 360 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosi Phthalas | | | | Lactosum | 90 mg | | | Magnesii Stearas | | | | Maydis Amylum | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 120 Tablet(s) | 229.66 | 266.20 | B | SL | No |
|
|
